| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |